Tapewire

Nasdaq · USD

ISRG

INTUITIVE SURGICAL INC

Export transactions ↓
Tapewire entity
2878
SEC CIK
0001035267
Parsed reports
1,605

Last 12 months

Inside the activity.

0 purchase rows · 74 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025011
Dec 202507
Jan 202606
Feb 202606
Mar 202609
Apr 202602
May 202606
Jun 202607
Jul 202605
Aug 202609
Sep 202606
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 28, 2020 Filed Sep 1, 2020 15:50 UTC
Curet MyriamEVP & Chief Medical Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 4,510 $0.00 Strike: $727.01 $0.00
Disclosure

SEC source: 0001035267-20-000150 · edgardoc.xml · derivative · entry 1

Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,510

Underlying: Common Stock · 4,510 shares

Expires 2030-08-28

F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
August 28, 2020 Filed Sep 1, 2020 15:55 UTC
Curet MyriamEVP & Chief Medical Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 4,510 $0.00 Strike: $727.01 $0.00
Disclosure

SEC source: 0001035267-20-000152 · edgardoc.xml · derivative · entry 1

Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,510

Underlying: Common Stock · 4,510 shares

Expires 2030-08-28

F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
August 28, 2020 Filed Sep 1, 2020 16:06 UTC
DeSantis RobertExecutive VP & GM IA&E
GrantNon-Qualified Stock Option (right to buy) · Derivative 1,449 $0.00 Strike: $727.01 $0.00
Disclosure

SEC source: 0001035267-20-000154 · edgardoc.xml · derivative · entry 1

DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,449

Underlying: Common Stock · 1,449 shares

Expires 2030-08-28

F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
August 28, 2020 Filed Sep 1, 2020 16:57 UTC
MOHR MARSHALLExecutive VP & CFO
GrantNon-Qualified Stock Option (right to buy) · Derivative 4,510 $0.00 Strike: $727.01 $0.00
Disclosure

SEC source: 0001035267-20-000156 · edgardoc.xml · derivative · entry 1

MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,510

Underlying: Common Stock · 4,510 shares

Expires 2030-08-28

F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
August 25, 2020 Filed Aug 26, 2020 21:37 UTC GiftCommon Stock 6,000 $0.00 $0.00
Disclosure

SEC source: 0001035267-20-000138 · edgardoc.xml · nonDerivative · entry 1

Johnson Amal M · CIK 0001388397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,468

F1 · kind: This transaction involved a gift of securities by the reporting person to her daughter, who lives outside of the reporting person's household. The reporting person no longer has beneficial ownership of these shares.

Read SEC document
August 18, 2020 Filed Aug 19, 2020 15:11 UTC
Curet MyriamEVP & Chief Medical Officer
GiftCommon Stock 80 $0.00 $0.00
Disclosure

SEC source: 0001035267-20-000136 · edgardoc.xml · nonDerivative · entry 1

Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,986

F1 · kind: These shares were gifted to the Bryn Mawr College.

Read SEC document
August 05, 2020 Filed Aug 6, 2020 20:59 UTC
Rosa David J.EVP and Chief Business Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 24,000 $0.00 Strike: $113.73 $0.00
Disclosure

SEC source: 0001035267-20-000134 · edgardoc.xml · derivative · entry 3

Rosa David J. · CIK 0001519593 · EVP and Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,000 shares

Expires 2021-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13,2021.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
August 05, 2020 Filed Aug 6, 2020 20:59 UTC
Rosa David J.EVP and Chief Business Officer
SaleCommon Stock 16,840 $693.02 $11,670,416.38
Disclosure

SEC source: 0001035267-20-000134 · edgardoc.xml · nonDerivative · entry 2

Rosa David J. · CIK 0001519593 · EVP and Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,479

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13,2021.

F2 · price: The average selling price for the transaction was $693.017550. The shares sold at $685.32 - $655.54 = 200 shares; $686.75 = 600 shares; $687.65 = 320 shares; $689.245 - $689.79 = 1,100 shares; $690.493 = 200 shares; $691.00 - $$691.90 = 1,906 shares; $692.279 - $693.018 = 2,443 shares; $693.06 - $$693.97 = 2,432 shares; $694.20 - $694.99 = 4,179 shares; $695.00 - $695.82 = 2,915 shares; $696.44 - $696.51 = 345 shares; $697 = 200 shares

Read SEC document
August 05, 2020 Filed Aug 6, 2020 20:59 UTC
Rosa David J.EVP and Chief Business Officer
Exercise / conversionCommon Stock 24,000 $113.73 $2,729,520.00
Disclosure

SEC source: 0001035267-20-000134 · edgardoc.xml · nonDerivative · entry 1

Rosa David J. · CIK 0001519593 · EVP and Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,319

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13,2021.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 00:42 UTC
MOHR MARSHALLExecutive VP & CFO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 7,500 $0.00 Strike: $127.91 $0.00
Disclosure

SEC source: 0001035267-20-000132 · edgardoc.xml · derivative · entry 4

MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 7,500 shares

Expires 2023-08-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 1, 2020.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 00:42 UTC
MOHR MARSHALLExecutive VP & CFO
SaleCommon Stock 7,500 $677.19 $5,078,930.25
Disclosure

SEC source: 0001035267-20-000132 · edgardoc.xml · nonDerivative · entry 2

MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,672

F1 · kind: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 1, 2020.

F2 · price: The average selling price for the transaction was $677.19071. The shares sold at $670.49 = 500 shares; $673.07 = 120 shares; $674.23 =100 shares; $674.58 = 400 shares; $675 - $675.01 = 950 shares; $676 = 750 shares; $677 - $677.96 = 1,100 shares; $678 - $678.76 = 1,100 shares; $680 - $680.34 = 2,480 shares.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 00:42 UTC
MOHR MARSHALLExecutive VP & CFO
Exercise / conversionCommon Stock 7,500 $127.91 $959,325.00
Disclosure

SEC source: 0001035267-20-000132 · edgardoc.xml · nonDerivative · entry 1

MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,172

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 1, 2020.

Read SEC document
July 24, 2020 Filed Jul 27, 2020 22:55 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 450 $0.00 Strike: $189.74 $0.00
Disclosure

SEC source: 0001035267-20-000126 · edgardoc.xml · derivative · entry 6

Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 450 shares

Expires 2023-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 26, 2021.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
July 24, 2020 Filed Jul 27, 2020 22:55 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 437 $0.00 Strike: $178.39 $0.00
Disclosure

SEC source: 0001035267-20-000126 · edgardoc.xml · derivative · entry 5

Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 437 shares

Expires 2026-02-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 26, 2021.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
July 24, 2020 Filed Jul 27, 2020 22:55 UTC
Curet MyriamEVP & Chief Medical Officer
SaleCommon Stock 450 $665.13 $299,308.50
Disclosure

SEC source: 0001035267-20-000126 · edgardoc.xml · nonDerivative · entry 4

Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,066

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 26, 2021.

Read SEC document
July 24, 2020 Filed Jul 27, 2020 22:55 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 450 $189.74 $85,381.52
Disclosure

SEC source: 0001035267-20-000126 · edgardoc.xml · nonDerivative · entry 3

Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,516

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 26, 2021.

Read SEC document
July 24, 2020 Filed Jul 27, 2020 22:55 UTC
Curet MyriamEVP & Chief Medical Officer
SaleCommon Stock 437 $665.13 $290,661.81
Disclosure

SEC source: 0001035267-20-000126 · edgardoc.xml · nonDerivative · entry 2

Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,066

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 26, 2021.

Read SEC document
July 24, 2020 Filed Jul 27, 2020 22:55 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 437 $178.39 $77,954.99
Disclosure

SEC source: 0001035267-20-000126 · edgardoc.xml · nonDerivative · entry 1

Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,503

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 26, 2021.

Read SEC document
July 24, 2020 Filed Jul 27, 2020 23:00 UTC
Ladd Amy LDirector
SaleCommon Stock 55 $665.13 $36,582.15
Disclosure

SEC source: 0001035267-20-000128 · edgardoc.xml · nonDerivative · entry 1

Ladd Amy L · CIK 0001781750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 11, 2021.

Read SEC document
July 24, 2020 Filed Jul 28, 2020 14:42 UTC
DeSantis RobertExecutive VP & GM IA&E
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 382 $0.00 $0.00
Disclosure

SEC source: 0001035267-20-000130 · edgardoc.xml · derivative · entry 7

DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 382 shares

Expires 2026-08-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The exercise price to the shares underlying this grant is $230.9967, equal to 100% of the closing FMV of the Company on the date of grant.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021.

F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
July 24, 2020 Filed Jul 28, 2020 14:42 UTC
DeSantis RobertExecutive VP & GM IA&E
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 383 $0.00 Strike: $178.39 $0.00
Disclosure

SEC source: 0001035267-20-000130 · edgardoc.xml · derivative · entry 6

DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 383 shares

Expires 2026-02-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021.

F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
July 24, 2020 Filed Jul 28, 2020 14:42 UTC
DeSantis RobertExecutive VP & GM IA&E
SaleCommon Stock 383 $665.57 $254,912.77
Disclosure

SEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 5

DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,348

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021.

F3 · price: The average selling price for the transaction was $665.568628. The shares sold at $663.08-$663.42 = 400 shares;$665.13 = 12 shares;$666.66 = 100 shares; $667.65 - $667.65 = 100 shares; 668.98 = 100 shares; $670.44 - $670.47 = 53 shares.

Read SEC document
July 24, 2020 Filed Jul 28, 2020 14:42 UTC
DeSantis RobertExecutive VP & GM IA&E
Exercise / conversionCommon Stock 383 $178.39 $68,322.11
Disclosure

SEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 4

DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,731

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021.

Read SEC document
July 24, 2020 Filed Jul 28, 2020 14:42 UTC
DeSantis RobertExecutive VP & GM IA&E
SaleCommon Stock 382 $665.57 $254,247.21
Disclosure

SEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 3

DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,348

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021.

F3 · price: The average selling price for the transaction was $665.568628. The shares sold at $663.08-$663.42 = 400 shares;$665.13 = 12 shares;$666.66 = 100 shares; $667.65 - $667.65 = 100 shares; 668.98 = 100 shares; $670.44 - $670.47 = 53 shares.

Read SEC document
July 24, 2020 Filed Jul 28, 2020 14:42 UTC
DeSantis RobertExecutive VP & GM IA&E
Exercise / conversionCommon Stock 382 $231.00 $88,240.74
Disclosure

SEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 2

DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,730

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021.

Read SEC document
July 24, 2020 Filed Jul 28, 2020 14:42 UTC
DeSantis RobertExecutive VP & GM IA&E
SaleCommon Stock 1,033 $666.69 $688,687.88
Disclosure

SEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 1

DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,348

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021.

F2 · price: The average selling price for the transaction was $666.687162. The shares sold at $663.33-$663.42 = 300 shares; $664.75 - $664.84 = 200 shares; $665.13 = 17 shares; $667.65 = 100 shares; $668 = 100 shares; $670.133 - $670.65 = 316 shares.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:10 UTC SaleCommon Stock 20 $663.33 $13,266.60
Disclosure

SEC source: 0001035267-20-000109 · edgardoc.xml · nonDerivative · entry 1

NACHTSHEIM JAMI K · CIK 0001223017 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,087

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on October 26, 2020.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:13 UTC
LEVY ALAN JDirector
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,800 $0.00 Strike: $193.08 $0.00
Disclosure

SEC source: 0001035267-20-000111 · edgardoc.xml · derivative · entry 3

LEVY ALAN J · CIK 0001280627 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,800

Underlying: Common Stock · 1,800 shares

Expires 2022-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 30, 2020.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:13 UTC
LEVY ALAN JDirector
SaleCommon Stock 1,800 $670.71 $1,207,275.48
Disclosure

SEC source: 0001035267-20-000111 · edgardoc.xml · nonDerivative · entry 2

LEVY ALAN J · CIK 0001280627 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,839

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 30, 2020.

F2 · price: The average selling price for the transaction was $670.708645. The shares sold at $663.33= 27 shares;$665.00 = 100 shares;$667.57-$667.74 = 197 shares; $668.66 - $668.93 = 300 shares; $670.07 - $670.38 = 207 shares; $671.89 - $671.99 = 333 shares; $672.64 - 100 shares; $673.11 - $673.57 - 436 shares; $674.21 = 100 shares.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:13 UTC
LEVY ALAN JDirector
Exercise / conversionCommon Stock 1,800 $193.08 $347,544.00
Disclosure

SEC source: 0001035267-20-000111 · edgardoc.xml · nonDerivative · entry 1

LEVY ALAN J · CIK 0001280627 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,639

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 30, 2020.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 90 $0.00 Strike: $548.50 $0.00
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · derivative · entry 18

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 937

Underlying: Common Stock · 90 shares

Expires 2029-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Awards Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 107 $0.00 Strike: $522.77 $0.00
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · derivative · entry 17

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 683

Underlying: Common Stock · 107 shares

Expires 2028-08-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 91 $0.00 Strike: $499.87 $0.00
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · derivative · entry 16

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 936

Underlying: Common Stock · 91 shares

Expires 2029-08-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 108 $0.00 Strike: $418.56 $0.00
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · derivative · entry 15

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 683

Underlying: Common Stock · 108 shares

Expires 2028-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 178 $0.00 Strike: $328.46 $0.00
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · derivative · entry 14

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 415

Underlying: Common Stock · 178 shares

Expires 2027-08-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 178 $0.00 Strike: $238.91 $0.00
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · derivative · entry 13

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416

Underlying: Common Stock · 178 shares

Expires 2027-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
SaleCommon Stock 90 $663.33 $59,699.70
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 12

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
Exercise / conversionCommon Stock 90 $548.50 $49,365.00
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 11

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 297

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
SaleCommon Stock 91 $663.33 $60,363.03
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 10

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
Exercise / conversionCommon Stock 91 $499.87 $45,488.17
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 9

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
SaleCommon Stock 178 $663.33 $118,072.74
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 8

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
Exercise / conversionCommon Stock 178 $238.91 $42,526.57
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 7

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 385

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
SaleCommon Stock 178 $663.33 $118,072.74
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 6

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
Exercise / conversionCommon Stock 178 $328.46 $58,465.29
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 5

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 385

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
SaleCommon Stock 108 $663.33 $71,639.64
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 4

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
Exercise / conversionCommon Stock 108 $418.56 $45,204.48
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 3

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
SaleCommon Stock 107 $663.33 $70,976.31
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 2

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 19:15 UTC
Samath JamieSVP of Finance
Exercise / conversionCommon Stock 107 $522.77 $55,936.39
Disclosure

SEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 1

Samath Jamie · CIK 0001330269 · SVP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 314

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 17:38 UTC
Rosa David J.EVP and Chief Business Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 24,000 $0.00 Strike: $113.73 $0.00
Disclosure

SEC source: 0001035267-20-000103 · edgardoc.xml · derivative · entry 3

Rosa David J. · CIK 0001519593 · EVP and Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2021-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13,2021.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 17:38 UTC
Rosa David J.EVP and Chief Business Officer
SaleCommon Stock 17,950 $553.49 $9,935,204.74
Disclosure

SEC source: 0001035267-20-000103 · edgardoc.xml · nonDerivative · entry 2

Rosa David J. · CIK 0001519593 · EVP and Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,319

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13,2021.

F2 · price: The average selling price for the transaction was $553.49326. The shares sold at $544.87 = 100 shares; $546.247 - $546.50 = 1,323 shares; $547.20 - $547.87 = 1,100 shares; $548.41 - $548.98 = 525 shares; $549.97 - $549.98 - 1,600 shares; $550.15 - $550.72 = 2,304 shares; $551.02 - $551.709 = 250 shares; $552.31 - $552.31 = 400 shares; $555 - $555.03 = 3,350 shares; $556.34 - $556.88 = 1,156 shares; $557.08 - $557.955 = 2,628 shares; $558 - $558.33 = 3,214 shares.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.